IGF-1 LR3 Dosage Guide
Complete guide to IGF-1 LR3 dosing protocols, administration methods, and safety considerations for research purposes.
Dosage Overview
Dose per Injection
20 mcg – 100 mcg
Frequency
Once per day
Route
subcutaneous
Cycle Length
4–6 weeks
Reconstitution
Vial Size
1 mg
BAC Water
1.0 ml
Concentration
1,000 mcg/ml
Detailed Dosage Information
Research protocols typically use 20-100mcg daily, often divided into multiple injections or administered bilaterally to target muscles.
Administration Method
Intramuscular injection (site-specific growth) or subcutaneous for systemic effects. Often cycled 4-6 weeks on, equal time off.
Research Use Only: All dosage ranges and calculations are derived from published research literature and are provided for educational purposes. These are not prescriptions or medical recommendations. Consult a healthcare professional before any use.
Concentration: 1 mg/ml
Volume to inject: 0.060 ml
Syringe units: 6.0 units — fits 0.3 ml syringe
U-100 insulin syringe (100 units = 1 ml). Verify dose with a clinician before injecting.
Pre-filled with IGF-1 LR3 defaults. Adjust values as needed.
Side Effects to Monitor
Hypoglycemia, joint pain, water retention, potential jaw/hand growth with extended use, and injection site reactions.
Safety Considerations & Risks
May promote growth of existing tumors. Can cause significant hypoglycemia. Long-term effects on insulin sensitivity concerning.